CA-NETAPP
9.12.2021 14:02:09 CET | Business Wire | Press release
NetApp® (NASDAQ: NTAP), a global, cloud-led, data-centric software company, today revealed findings from its survey assessing the adoption of hybrid cloud strategies and operational focus areas among NetApp’s global enterprise customer base.
The survey of IT decision makers and infrastructure owners around the world found that 77 percent plan to operate their businesses in hybrid cloud environments for the foreseeable future in order to meet growing business demands for faster innovation, while optimizing operations and lowering infrastructure costs.
“Speed is the new scale. IT leaders everywhere are accelerating digital transformation efforts, requiring more agility and flexibility to stay ahead of their competition and deliver immediate business impact,” said Ronen Schwartz, General Manager and Senior Vice President, Cloud Volumes at NetApp. “Enterprises are embracing hybrid cloud models to effectively scale out IT resources to support business-critical applications and workloads – and NetApp is leading the industry in providing hybrid multi-cloud solutions to meet these organizations wherever they are.”
Highlights from NetApp’s 2021 Hybrid Cloud Enterprise Customer Adoption Survey include:
-
The Future is Hybrid Cloud
: More than three-quarters of respondents said their organization plans to operate a hybrid cloud environment for the foreseeable future, while only 17 percent expect their organization to eventually migrate all IT to the cloud. Those surveyed listed the most important business benefits of hybrid cloud adoption to be:
- Faster Innovation - 26 percent
- Increased Responsiveness to Customers - 25 percent
- Increased Collaboration - 22 percent
- Key Operational Drivers for Hybrid Cloud Adoption : Respondents indicated they are looking to improve infrastructure flexibility and scale (27 percent), as hybrid cloud designs help IT teams get access to the on-demand and emerging technologies offered by public cloud while still leveraging legacy systems running reliably on-premises. Nearly a quarter (21 percent) said they needed to optimize costs, while 13 percent said they needed to improve data accessibility.
- Data Protection Remains Top Priority with Other Use Cases Gaining Traction : Data protection (including disaster recovery, backup and archiving) was the most popular hybrid cloud use case selected with 29 percent stating they are either utilizing hybrid cloud for data protection today or plan to within 24 months. However, customer respondents indicated they are also leveraging hybrid cloud for production use cases more than anticipated: 20 percent said they are currently integrating both on-premises and cloud resources to support the same workload for hybrid production, with 17 percent planning to do so within 24 months.
Innovative Organizations Continue to Succeed with NetApp Hybrid Cloud Solutions
The survey data shows that organizations all over the world are adopting a hybrid cloud strategy and relying on NetApp’s industry-leading solutions to accelerate their digital transformation and deliver business value faster.
“We needed the flexibility and agility of a hybrid cloud architecture to more effectively manage the massive amounts of data being generated daily across our global manufacturing facilities and development sites to accelerate time to insights and better inform decision making,” said Rohit Agrawal, Global Head of Hybrid Cloud at Siemens Healthineers. “NetApp’s hybrid cloud solutions help us streamline data center operations and keep costs under control, with the ability to centralize, manage, and secure the mission-critical data and applications.”
Methodology
The survey was conducted by NetApp among 79 organizations (54% AMER, 36% EMEA, 10% APAC) representing large and midsized organizations across diverse industries that have deployed or plan to deploy hybrid cloud architectures with NetApp.
Additional Resources
About NetApp
NetApp is a global cloud-led, data-centric software company that empowers organizations to lead with data in the age of accelerated digital transformation. The company provides systems, software and cloud services that enable them to run their applications optimally from data center to cloud, whether they are developing in the cloud, moving to the cloud, or creating their own cloudlike experiences on premises. With solutions that perform across diverse environments, NetApp helps organizations build their own data fabric and securely deliver the right data, services and applications to the right people—anytime, anywhere. Learn more at www.netapp.com or follow us on Twitter , LinkedIn , Facebook , and Instagram .
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211209005346/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
